HCV Envelope glycoprotein E1 Mouse Monoclonal Antibody [Clone ID: BDI198]
CAT#: BM3324
HCV Envelope glycoprotein E1 mouse monoclonal antibody, clone BDI198, Purified
Need it in bulk or conjugated?
Get a free quote
CNY 15,038.00
货期*
5周
规格
Cited in 5 publications. |
Product images
Specifications
Product Data | |
Clone Name | BDI198 |
Applications | ELISA, IF, IHC, WB |
Recommend Dilution | IFA. ELISA. Western blot. Immunohistochemistry. |
Reactivity | Hepatitis C Virus |
Host | Mouse |
Clonality | Monoclonal |
Immunogen | Recombinant HCV E1 glycoprotein (genotype 1b). |
Specificity | Specific to HCV E1. |
Formulation | 0.01M PBS, pH 7.2 containing 0.09% Sodium Azide as preservative without stabilizing proteins State: Purified State: Liquid purified Ig fraction from Ascites (> 90% pure) |
Concentration | lot specific |
Purification | Protein A Chromatography |
Conjugation | Unconjugated |
Storage Condition | Upon receipt, store (in aliquots) at -20°C. Avoid repeated freezing and thawing. |
Background | Envelope glycoproteins E1 and E2 are involved in virus attachment to the host cell as well as in virus endocytosis and fusion with host membrane. E2 inhibits human EIF2AK2/PKR activation, preventing the establishment of an antiviral state. E2 is a viral ligand for CD209/DC-SIGN and CLEC4M/DC-SIGNR, which are respectively found on dendritic cells (DCs), and on liver sinusoidal endothelial cells and macrophage-like cells of lymph node sinuses. These interactions allow capture of circulating HCV particles by these cells and subsequent transmission to permissive cells. DCs are professional antigen presenting cells, critical for host immunity by inducing specific immune responses against a broad variety of pathogens. They act as sentinels in various tissues where they entrap pathogens and convey them to local lymphoid tissue or lymph node for establishment of immunity. Capture of circulating HCV particles by these SIGN+ cells may facilitate virus infection of proximal hepatocytes and lymphocyte subpopulations and may be essential for the establishment of persistent infection. |
Synonyms | Heptitis C Virus E1, gp32, gp35 |
Reference Data |
Citations (5)
The use of this Antibodies has been cited in the following citations: |
---|
Enhancing Hepatitis C virus pseudoparticles infectivity through p7NS2 cellular expression.
,null,
Journal of virological methods
,PubMed ID 31412271
[E1]
|
Pseudotyping retrovirus like particles vaccine candidates with Hepatitis C virus envelope protein E2 requires the cellular expression of CD81
,Soares, HR;Castro, R;Tomás, HA;Carrondo, MJT;Alves, PM;Coroadinha, AS;,
AMB Express
,PubMed ID 30729353
[E1]
|
Removal of the C6 Vaccinia Virus Interferon-β Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene Expression
,null,
Viruses
,PubMed ID 30096846
[E1]
|
High-yield production of a chimeric glycoprotein based on permuted E1 and E2 HCV envelope ectodomains
,Tello D, RodrC-guez-RodrC-guez M, YC)lamos B, GC3mez-GutiC)rrez J, Peterson DL, Gavilanes F,
J. Virol. Methods
,PubMed ID 25486085
[E1]
|
High, Broad, Polyfunctional, and Durable T Cell Immune Responses Induced in Mice by a Novel Hepatitis C Virus (HCV) Vaccine Candidate (MVA-HCV) Based on Modified Vaccinia Virus Ankara Expressing the Nearly Full-Length HCV Genome
,null,
Journal of Virology
,PubMed ID 23596307
[E1]
|
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |
Customer
Reviews
Loading...